Partial splenic artery embolization in cirrhotic patients

Table 2 Complications in partial splenic artery embolization

Ref.	Year	Country	Study type	Complication: Frequency of post embolization syndrome	Complication: Mean length of post embolization syndrome-Days	Major complications: Total number	Persistant thrombocytopenia	Splenomegaly	Pleural effusion/ascites	Variceal bleeding	Portal vein thrombosis	Bacterial peritonitis	Splenic abscess	PSE-related death	Repeat embolization required
Kim et al[11]	2012	South Korea	Case series report	100.00%	Not provided	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Elmonem et al[12]	2010	Egypt	Case series report	91.30%	Not provided	34.80%	4.30%	4.30%	8.70%	0.00%	4.30%	4.30%	4.30%	4.30%	4.30%
Zhu et al[14]	2009	China	Nonrandomized prospective trial	Total 85.5% Group A: 100% Group B: 91.2% Group C: 62.5%	Group A: 13 Group B: 7 Group C: 3	Total 14.5% Group A: 50% Group B: 8.8% Group C: 0%	Total 0% Group A: 0% Group B: 0% Group C: 0%	Total 0% Group A: 0% Group B: 0% Group C: 0%	Total 4.8% Group A: 16.6% Group B: 2.9% Group C: 0%	Total 1.6% Group A: 8.3% Group B: 0% Group C: 0%	Total 1.6% Group A: 8.3% Group B: 0% Group C: 0%	Total 1.6% Group A: 8.3% Group B: 2.9% Group C: 0%	Total 1.6% Group A: 8.3% Group B: 0% Group C: 0%	Total 1.6% Group A: 8.3% Group B: 0% Group C: 0%	Total 0% Group A: 0% Group B: 0% Group C: 0%
Amin et al[9]	2009	Egypt	Randomized control trial	Not provided	PSE: 2.1 (0.4) SPL: 4.3 (1.1)	PSE: 25% SPL: 25%	PSE: 0% SPL: 0%	PSE: 0% SPL: 0%	PSE: 10% SPL: 10%	PSE: 0% SPL: 0%	PSE: 5% SPL: 15%	PSE: 0% SPL: 0%	PSE: 5% SPL: 0%	PSE: 5% SPL: 0%	PSE: 0% SPL: 0%
Zhu et al[16]	2008	China	Randomized control trial	GF: 90.6% PVA: 100%	GF: 6.4 (3.6) PVA: 7.6 (2.8)	GF: 25.0% PVA: 21.4%	GF: 0% PVA: 0%	GF: 0% PVA: 0%	GF: 9.4% PVA: 10.7%	GF: 3.1% PVA: 3.6%	GF: 3.1% PVA: 7.1%	GF: 6.3% PVA: 0%	GF: 3.1% PVA: 0%	GF: 3.1% PVA: 0%	GF: 0% PVA: 0%
Hayashi et al[17]	2007	Japan	Nonrandomized prospective trial	100.00%	Not provided	11.90%	0.00%	0.00%	9.50%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Lee et al[15]	2007	China	Nonrandomized prospective trial	100.00%	Not provided	10.00%	0.00%	0.00%	10.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
N'Kontchou et al[13]	2005	France	Retrospective review	78.10%	14	28.10%	3.10%	0.00%	6.30%	0.00%	6.30%	0.00%	6.30%	6.3%1	3.10%

¹Both deaths in the trial were in patients with > 70% splenic embolization. PSE: Partial splenic artery embolization; SPL: Splenectomy; GF: Gel foam; PVA: Polyvinyl alcohol.